Toth Financial Advisory Corp grew its holdings in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 13.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 59,937 shares of the company’s stock after buying an additional 7,124 shares during the period. Toth Financial Advisory Corp’s holdings in Colgate-Palmolive were worth $5,114,000 as of its most recent SEC filing.
A number of other institutional investors also recently bought and sold shares of CL. State Street Corp grew its stake in Colgate-Palmolive by 97.4% in the second quarter. State Street Corp now owns 94,195,992 shares of the company’s stock worth $8,635,889,000 after purchasing an additional 46,476,510 shares during the period. Bank of New York Mellon Corp grew its position in shares of Colgate-Palmolive by 8.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 13,532,417 shares of the company’s stock worth $1,240,652,000 after buying an additional 1,010,872 shares during the period. Deutsche Bank AG grew its position in shares of Colgate-Palmolive by 33.9% in the 4th quarter. Deutsche Bank AG now owns 10,845,857 shares of the company’s stock worth $857,040,000 after buying an additional 2,746,920 shares during the period. First Eagle Investment Management LLC increased its stake in shares of Colgate-Palmolive by 1.1% in the 2nd quarter. First Eagle Investment Management LLC now owns 8,205,699 shares of the company’s stock worth $752,298,000 after acquiring an additional 88,917 shares in the last quarter. Finally, Amundi boosted its stake in Colgate-Palmolive by 19.9% during the second quarter. Amundi now owns 6,218,257 shares of the company’s stock worth $570,090,000 after acquiring an additional 1,033,918 shares in the last quarter. 80.41% of the stock is owned by institutional investors.
Insiders Place Their Bets
In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 10,000 shares of the firm’s stock in a transaction dated Monday, August 24th. The stock was sold at an average price of $92.05, for a total value of $920,500.00. Following the transaction, the chief operating officer directly owned 64,901 shares of the company’s stock, valued at approximately $5,974,137.05. This trade represents a 13.35% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director John Cahill sold 4,170 shares of the business’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $93.37, for a total value of $389,352.90. Following the sale, the director owned 28,373 shares of the company’s stock, valued at approximately $2,649,187.01. This represents a 12.81% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 175,191 shares of company stock valued at $16,110,903. Insiders own 0.43% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Analysis on Colgate-Palmolive
Colgate-Palmolive Stock Performance
NYSE:CL traded up $0.72 during trading hours on Thursday, reaching $87.93. The company had a trading volume of 1,261,403 shares, compared to its average volume of 5,688,848. The firm has a market cap of $70.09 billion, a price-to-earnings ratio of 34.98, a PEG ratio of 4.07 and a beta of 0.33. The company has a current ratio of 1.03, a quick ratio of 0.67 and a debt-to-equity ratio of 13.82. The firm’s 50 day moving average price is $89.23 and its 200-day moving average price is $88.75. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33.
Colgate-Palmolive (NYSE:CL – Get Free Report) last released its quarterly earnings results on Friday, July 31st. The company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.95 by $0.04. The firm had revenue of $5.36 billion for the quarter, compared to analysts’ expectations of $5.36 billion. Colgate-Palmolive had a return on equity of 464.63% and a net margin of 9.68%.During the same period in the prior year, the firm earned $0.92 EPS. The company’s revenue was up 4.9% compared to the same quarter last year. On average, analysts forecast that Colgate-Palmolive Company will post 3.87 EPS for the current year.
Colgate-Palmolive Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Tuesday, October 20th will be issued a $0.53 dividend. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio is currently 84.13%.
Colgate-Palmolive Profile
Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwashes, body washes, deodorants, soaps, household cleaning products and pet food and treats.
The company markets many of its products under well-known brands, including Colgate, Palmolive, elmex, meridol, Protex, Softsoap, Ajax, Irish Spring, Speed Stick, Tom’s of Maine and Hill’s Science Diet.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
- This Space ETF Offers SpaceX Exposure—But Investors Are Paying for the Volatilit
- Does Lemonade’s Growth Signal Profits Ahead?
- These 3 ETFs Could Benefit From the Parts of Inflation That Won’t Go Away
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
